Tolvaptan Improves the Diurnal Blood Pressure Profile in Patients with Hypertension and Autosomal Dominant Polycystic Kidney Disease [0.03%]
Masaaki Hanaoka,Hiromichi Wakui,Daisuke Kanai et al.
Masaaki Hanaoka et al.
Background: Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder frequently associated with non-dipper hypertension, with tolvaptan being the only currently approved treatment. However, the effects o...
ADAM17 expression in ACEI/ARB-treated patients with hypertension was comparable to that observed in patients without hypertension [0.03%]
Nora L Falcoff,Gabriela R Guman,Rolando F Seguel et al.
Nora L Falcoff et al.
Background: ADAM17 (A disintegrin and metalloproteinase 17) contributes to angiotensin-converting enzyme (ACE) 2 shedding in response to angiotensin II-AT1 receptor signaling, potentially shifting the renin-angiotensin sy...
Healthcare Insurance Status and Hypertension Control Before and After the Affordable Care Act [0.03%]
Brent M Egan,Jiexiang Li,Susan E Sutherland et al.
Brent M Egan et al.
Background: Blood pressure control among adults
Evidence-Informed Prioritization of Interventions for Integrating Hypertension Management into Cardiovascular-Kidney-Metabolic Care in Primary Health Care: HEARTS 2.0 Phase 3 [0.03%]
高血压心血管代谢一体化防治项目HEARTS 2.0第三阶段：基层医疗卫生机构优先开展的基于循证的干预措施
Pedro Ordunez,Andres Rosende,Maria Florencia Grande Ratti et al.
Pedro Ordunez et al.
Background: HEARTS in the Americas is the regional adaptation of the WHO Global HEARTS Initiative. This paper presents Phase 3 of HEARTS 2.0, an evidence-informed process to prioritize clinical and health-system intervent...
Concurrent Hypertension and Obesity and the Risk of Incident Heart Failure: Insights from Two Prospective Cohort Studies [0.03%]
高血压和肥胖与心力衰竭发病风险的关系：来自两项前瞻性队列研究的启示
Dongjie Du,Yitian Chen,Weilan Li et al.
Dongjie Du et al.
Background: This study examined the association of hypertension and obesity with incident heart failure (HF) and the feasibility of the clinical obesity definition proposed by The Lancet Diabetes & Endocrinology Commissio...
Visit-to-visit systolic blood pressure variability and risk of severe hypertensive episodes in a multicenter cohort [0.03%]
访间收缩压变异性与多中心队列中高血压患者严重高血压发作风险的关系研究
Hyung Joon Joo,Youngho Seo,Soon Jun Hong et al.
Hyung Joon Joo et al.
Background: Visit-to-visit blood pressure variability has been associated with cardiovascular outcomes; however, its role in predicting severe blood pressure (BP) elevation requiring emergency department care remains unce...
Epigenetic Regulation in Hypertension: Mechanistic Insights and Environmental Influences [0.03%]
高血压的表观遗传调控：机制见解及环境影响
Sravan Perla,Alladi Charanraj Goud,Matthew Liu et al.
Sravan Perla et al.
Hypertension is a leading global cause of cardiovascular, renal, and cerebrovascular morbidity. Beyond classical genetic and environmental determinants, accumulating evidence highlights epigenetic regulation as a key contributor to blood pr...
Reconsidering the interpretation of "low-efficacy" antihypertensive initiation in older adults [0.03%]
重新考虑老年高血压患者初始使用“疗效较低”的降压药的解释方法
Chia Siang Kow,Abdullah Faiz Zaihan,Kaeshaelya Thiruchelvam
Chia Siang Kow